Twist Bioscience Corporation, commonly referred to as Twist Bioscience, is a pioneering synthetic biology company headquartered in the United States. Founded in 2013, the company has rapidly established itself as a leader in the biotechnology sector, focusing on DNA synthesis and gene editing technologies. With major operational regions across North America and Europe, Twist Bioscience serves a diverse range of industries, including pharmaceuticals, agriculture, and industrial biotechnology. The company’s core offerings include high-quality, scalable DNA synthesis solutions that are distinguished by their precision and efficiency. Twist Bioscience's innovative approach to DNA manufacturing has garnered significant recognition, positioning it as a key player in the synthetic biology market. Notable achievements include partnerships with leading research institutions and a commitment to advancing genetic research, making Twist Bioscience a vital contributor to the future of biotechnology.
How does Twist Bioscience Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Twist Bioscience Corporation's score of 30 is lower than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Twist Bioscience Corporation, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges available at this time. As a result, the company does not have any publicly stated commitments to reduce emissions or specific initiatives aimed at addressing climate change. This lack of data suggests that Twist Bioscience may still be in the early stages of developing a comprehensive climate strategy or reporting framework. In the context of the biotechnology industry, companies are increasingly expected to set ambitious climate targets and transparently report their emissions. Without such commitments or data, Twist Bioscience may face challenges in aligning with industry standards and stakeholder expectations regarding sustainability and climate action.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Twist Bioscience Corporation is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.